STERILITY PREPARATION

0.0(0)
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/73

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

74 Terms

1
New cards

sterility test

This test is aimed at finding out if there are any living microorganisms in pharmaceutical products such as powders and granules for injections that are intended to be sterile. This guarantees that the product contains no contaminating microorganisms prior to administration

2
New cards

Injectable solutions, ophthalmic preparations, sterile powders, implants, and medical devices

types of final dosage form in sterility testing

3
New cards

membrane filtration

A purification process in which liquid is passed through a special membrane filter that retains microorganisms

4
New cards

direct inoculation

A method of sterility testing in which culture media is inoculated with microorganisms and kept under conditions favorable for growth

5
New cards

culture media

Solutions that contain nutrients and are used during the sterility testing to propagate microorganisms.

6
New cards

incubation period

The period of time during which the inoculated culture media are kept in specified conditions in order to allow the organisms to multiply

7
New cards

sterility

The complete absence of viable microorganisms in a products

8
New cards

membrane filtration method

The product is passed through a sterile membrane, and the filter is incubated in a growth medium. Uses Membrane filtration unit, incubators, culture media.

9
New cards

direct inoculation method

The sample is directly inoculated into a growth medium and incubated for microbial growth.

10
New cards

Fluid Thioglycollate Medium and Soybean Casein Digest Medium

Culture Media: Such as ___which allows anaerobic and aerobic microorganisms’ growth, respectivel

11
New cards

sterility test

Statistical Formula: No specific statistical formula, relies on incubation and observation.

Result: No microbial growth observed after incubation.

Standard Value: The set of procedures to perform a sterility test and acceptance criteria are described in the pharmacopoeia such as United States Pharmacopeia (USP), European Pharmacopoeia (EP) and World Health Organization (WHO) guideline

12
New cards

Bacterial Endotoxin Test (BET)

Detects endotoxins from Gram-negative bacteria in pharmaceutical preparations. The test is essential for injectable products and is commonly performed using the LAL test.

13
New cards

endotoxins

Gram-negative bacteria membranes that can lead to fever or shock in humans and contain biologically active amino acids

14
New cards

Gel-Clot Method

BET methods for endotoxins that do not require advanced systems. A simple gel will suffice.

15
New cards

Turbidimetric Method

Used in most quantitative clinical laboratories, it is used for BET to read the result of the reaction between the LAL and the endotoxin containing sample.

16
New cards

Chromogenic Method

chromogenic immunoassays (CIA's) are a promising robust platform for molecular diagnostic application

17
New cards

chromogenic immunoassays (CIA's)

are a promising robust platform for molecular diagnostic application

18
New cards

BET Test

Method: Statistical Formula: the test requires calculation of Endotoxin Maximum Valid Dilution (EMVD), which is the maximum dilution of the sample that can be done, and the endotoxins will still be detectable

19
New cards

MVD = Endotoxin Limit x Sample Concentration over λ

BET test formula

20
New cards

Incubating Device

It holds themreaction mixture at constant temperature which is 37 degrees Celsius plus or minus 1 degreemCelsius for a given amount of time.

21
New cards

Spectrophotometer

Employs in turbidimetric and chromogenic methods where changes in theturbidity or the intensity of the,color are measured

22
New cards

microplate reader

Used for kinetic chromogenic assays and other expansion methods where the absorbance of many samples is measured at the same time.

23
New cards

intravenous medications

Acceptable Result: The acceptable amount of endotoxin largely depends on the type of product and how it is administered. For ____, the limit is generally set at 5 Endotoxin Units (EU) per kilogram of body weight per hour.

24
New cards

intrathecal dosing

More restrictive benchmarks exist for ____ dosing at approximately 0.2 EU/kg/hr

25
New cards

BET Test

Standard Value: The test is based on the guideline and acceptance criteriamspecified in various pharmacopeial standards including United States Pharmacopeia (USP) l, European Pharmacopoeia (Ph. Eur.) , and Japanese Pharmacopoeia (JP); these references explain in detail the methods of study, calculation, and permissible values of contaminants for pharmaceutical preparation

26
New cards

Limulus Amebocyte Lysate (LAL)

Test: A specific method under BET that uses the blood extract of the horseshoe crab (Limulus polyphemus) to detect bacterial endotoxins through coagulation or color change

27
New cards

37°C ± 1°C

LAL test: For the Gel-Clot Method: Water bath or heating block maintained at ___ & Endotoxin-free glass test tube

28
New cards

microplate reader orspectrophotometer

LAL test: For the Chromogenic and Turbidimetric __ capable of measuring at specific wavelengths (e.g., 405-410 nm for chromogenic assays).

29
New cards

37°C ± 1°C

Incubation equipment to maintain

30
New cards

LAL test

Expected/Acceptable Result: Different products and their uses will require different levels of endotoxins. For example, the United States Pharmacopeia states there is an endotoxin limit of 0.25 Endotoxin Units (EU) per milliliter for Water for Injection. A particular product will only be acceptable if the results fall within the stipulated endotoxin limits for that product.

31
New cards

LAL test

Standard Value or System: The acceptance and the examination criteria are stated in USP guidelines, such as the United States Pharmacopeia (USP). In these guidelines, procedures along with sensitivity parameters have been established to carry out the

32
New cards

Pyrogen Test (Rabbit Test or LAL Test)

Evaluates the presence of fever-causing substances (pyrogens) in pharmaceutical products by injecting the test solution into rabbits and monitoring their temperature response

33
New cards

pyrogens

Fever-inducing substances that may be of microbial or chemical origin.

34
New cards

Fever Threshold

It is the range of temperature increase in rabbits that makes a sample potentially pyrogenic.

35
New cards

Coagulation Reaction

In the LAL test, endotoxins have the ability to gel andmself-clump into a solid clot. This is normally a sign of contamination

36
New cards

thermometers, animal keeping facilities, temperature surveillance systems

Equipment: Rabbit Test:

37
New cards

Microplate reader, LAL reagent, incubation system

LAL Test

38
New cards

(>0.5°C for individual rabbits or >1.4°C in three rabbits combined)

Result: No significant increase in rabbit body temperature __

39
New cards

pyrogen test

Pharmacopeial Standards:United States Pharmacopeia (USP) <151> Pyrogen Test

USP Bacterial Endotoxins Test European Pharmacopeia (EP) anJapanese Pharmacopeia (JP) guidelines

40
New cards

leaker’s test

is a quality control procedure used to detect defective or compromised containers in pharmaceutical packaging, particularly ampules and vials. The test ensures that these containers are properly sealed and can maintain sterility and integrity throughout their shelf life

41
New cards

vacuum pressure

A pressure level lower than the surrounding atmospheric pressure, used to force dye into leaks.

42
New cards

dye penetration

A method where a colored solution is used to detect leaks by entering compromised areas of a containers

43
New cards

vacuum pressure method

This method checks for leaks by placing containers in a vacuum chamber and reducing external pressure. If a container has a defect, air or liquid enters or escapes, revealing the leak.

44
New cards

Dye Penetration Test

involves submerging containers in a dye solution (e.g., methylene blue) under vacuum. The vacuum forces the dye into any cracks or leaks.

45
New cards

leaker’s test

Specific equipment used: Vacuum chamber, Dye solution (commonly methylene blue), magnifying lenses/automated inspection system

46
New cards

leaker’s test

Expected/Acceptable result: The absence of dye penetration in the container, indicating no leaks or defects. Containers with visible dye inside are rejected as defective.

47
New cards

leaker’s test

Pharmacopeial Standards:

  • United States Pharmacopeia (USP) <381> Elastomeric Closure Integrity

  • USP <1207> Package Integrity Evaluation

  • European Pharmacopeia (EP) guideline

48
New cards

Particulate Matter Test

is a quality control procedure used for removing, counting, and sizing undissolved particles in pharmaceutical products in injectables and parenteral solutions.

49
New cards

Particulate Matter Test

is required on all pharmaceutical products that come in contact with human blood or tissue

50
New cards

microscopy

A technique used to visualize and analyze the particulate matter under magnification.

51
New cards

Light Obscuration

A method to detect and count particles based on the interruption of light (usually a laser light source) by particles in a liquid

52
New cards

Light Obscuration Method

The solution is passed through a particle counter, where light interruption is used to detect and count particles.

53
New cards

laser diode

The light source is a ___, which illuminates individual particles in the stream to generate a shadow or blockage of light on the detector.

54
New cards

Particulate Matter Test

Statistical formula: uses statistical techniques such as; the Mean Particle Count per Volume

55
New cards

Particulate Matter Test

Specific Equipment used: HIAC, PAMAS (Light obscuration particle counters), and Computer Software

56
New cards

≤100 mL

PMT: Small-Volume Parenterals (SVPs) (__):

57
New cards

≤6000 particles per container

PMT small volume: Particles ≥10 µm: __

58
New cards

≤600 particles per container

PMT small volume: Particles ≥25 µm:

59
New cards

>100mL

Large-Volume Parenterals (LVPs) (__):

60
New cards

≤25 particles per mL

PMT large volume: Particles ≥10 µm:

61
New cards

≤3 particles per mL

PMT large volume: Particles ≥25 µm:

62
New cards

clarity test

This test assesses the transparency and absence of particulate matter/impurities in liquid pharmaceutical products. A clear solution indicates the absence of visible impurities, ensuring the product’s quality and safety.

63
New cards

turbidity

The cloudiness or haziness in a liquid caused by large numbers of individual particles

64
New cards

particulate matter

Undissolved particles, other than gas bubbles, present in the liquiid

65
New cards

clarity test

USP <790> Visible Particulates in Injections

USP <788> Particulate Matter in Injections

European Pharmacopeia (EP) 2.9.20

Clarity and Degree of Opalescence

66
New cards

safety test

This test evaluates whether a pharmaceutical product causes any toxic reactions when administered. It involves administering the product to test animals and observing for adverse effects, ensuring the product’s safety for human use.

67
New cards

Abnormal Toxicity Test

Safety Test is also known as the

68
New cards

toxicity

The degree to which a substance can harm humans or animals.

69
New cards

LD50 (Lethal Dose 50)

The dose of a substance that kills 50% of the test population.

70
New cards

safety test

Statistical Formula: The Safety Test involves observation of adverse effects, statistical analysis may be applied to interpret the data, especially in determining metrics like LD50.

71
New cards

safety test: Selection of Test Animals: Typically healthy ___are used.

72
New cards

intraperitoneal route

Administration: Inject a specified dose of the product into the animals, usually via the

73
New cards

safety test

Expected/Acceptable Result: No test animals should exhibit signs of toxicity or abnormal reactions during the observation period

74
New cards

safety test

Pharmacopeial Standards:

USP <88> Biological Reactivity Tests, In Vivo

USP <87> Biological Reactivity Tests, In Vitro

European Pharmacopeia (EP) 2.6.9

Abnormal Toxicity Test (historically used but now largely replaced) ICH Guidelines (International Council for Harmonization) for Toxicity Testin